Geron is an undervalued company with a potential for significant revenue growth, especially via its first-in-class drug ...

Mineralys Therapeutics, Inc.'s lorundrostat shows promise for treating aldosterone-driven hypertension with FDA approval by ...

Shares of Guardant Health Inc (NASDAQ:GH) climbed 3.7% as the company announced its Shield multi-cancer detection (MCD) test received Breakthrough Device designation from the U.S. Food and Drug ...

Amylyx Pharmaceuticals (NASDAQ:AMLX) said on Tuesday that the U.S. FDA has granted fast track status to its antisense RNA, ...

"Sickle cell disease is a devasting disorder that affects approximately 100,000 people in the U.S., leading to anemia, severe ...

ImmunityBio (NASDAQ:IBRX) said on Monday that the U.S. FDA has approved expanded access for its Cancer BioShield platform, ...

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to AMX0114, an ...

Company to meet with prospective partners as it accelerates toward IND submission for Telomir-1, with plans to begin human ...

"It is a pleasure to welcome Bill, a deeply experienced and proven commercial leader,” said Jesse Shefferman, Chief Executive ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from a Phase ...